3. Aims
spastic hemiplegia, cerebrovascular disease, shoulder pain, pain
SPASTIC HEMIPLEGIA, CEREBROVASCULAR DISEASE
To assess whether the use of 200 units of abobotulinum in the pectoralis major and subscapularis muscles modifies the pain complaint, evaluated by the visual analog scale, in subjects with shoulder pain after the onset of spastic hemiplegia due to cerebrovascular disease when compared to the application of a placebo to the same muscles, after 4 months. 